{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-051125","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.661678+00:00","generated_at":"2026-05-29T00:16:07.083233+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Propanc Biopharma raises ~$61k via two convertible notes with dilutive terms","bullets":["Dec 16 note: $22k principal ($20k proceeds), 8% interest, matures June 15, 2025; convertible at $0.0003/share (step-down to $0.0001).","Dec 20 note: $49.2k principal ($41k proceeds), 15% one-time interest, due Oct 15, 2025; conversion at 65% of lowest 10-day trading price.","Proceeds used for general working capital; notes are private placements under Rule 506.","Note terms include 4.99% beneficial ownership cap and prepayment premiums up to 125% face value."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-051125","json":"https://secwatch.observer/filing/0001493152-24-051125.json","markdown":"https://secwatch.observer/filing/0001493152-24-051125.md","text":"https://secwatch.observer/filing/0001493152-24-051125.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224051125/0001493152-24-051125-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224051125/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:16:07.083233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}